NASDAQ: CASI
Casi Pharmaceuticals Inc Stock Ownership - Who owns Casi Pharmaceuticals?

Insider buying vs selling

Have Casi Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CASI insiders and whales buy or sell their stock.

CASI Shareholders

What type of owners hold Casi Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene Corp153.30%23,750,000$43.70MInsider
Dapeng Li76.63%11,872,026$21.84MInsider
Sparkle Byte Ltd65.83%10,198,518$18.77MInsider
Spectrum Pharmaceuticals Inc64.85%10,047,675$18.49MInsider
Idgaccel China Growth Fund III LP63.08%9,773,370$17.98MInsider
Wealth Strategy Holding Ltd58.66%9,087,888$16.72MInsider
Weiwu He16.53%2,560,265$4.71MInsider
Foresite Capital Management VI LLC8.58%1,329,383$2.45MInstitution
Vr Adviser LLC6.37%987,259$1.82MInstitution
James Huang5.09%788,374$1.45MInsider

1 of 3

CASI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CASI3.34%96.66%
PULM4.43%95.57%
DYAI8.83%91.17%Net Buying
GRCE36.36%63.64%
INKT0.26%99.74%Net BuyingNet Buying

Casi Pharmaceuticals Stock Ownership FAQ

Who owns Casi Pharmaceuticals?

Casi Pharmaceuticals (NASDAQ: CASI) is owned by 17.71% institutional shareholders, 513.20% Casi Pharmaceuticals insiders, and 0.00% retail investors. Celgene Corp is the largest individual Casi Pharmaceuticals shareholder, owning 23.75M shares representing 153.30% of the company. Celgene Corp's Casi Pharmaceuticals shares are currently valued at $43.70M.

If you're new to stock investing, here's how to buy Casi Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.